Related Experiment Video
Updated: Jun 14, 2026
09:12
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
16.6K
Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells
Takahiro Tsuji1,2, Haruka Hirose3, Daisuke Sugiyama4
1Department of Anatomy and Molecular Cell Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Cancer Research
|December 10, 2025
Summary
Researchers uncovered how brain immune cells called microglia respond to early-stage brain metastases. Modulating these microglia may offer new therapeutic strategies for eliminating tumors before they spread.
Area of Science:
- Neuroscience
- Immunology
- Oncology
Background:
- Brain metastases are a common and fatal outcome of advanced cancers.
- Microglia, the brain's immune cells, have complex roles in established tumors, but their early-stage functions are unclear.
- Understanding early microglial responses is crucial for developing therapies against nascent brain tumors.
Purpose of the Study:
- To investigate the dynamic behavior and heterogeneity of microglial populations during the initial development of brain metastases.
- To identify molecular mechanisms regulating microglial phenotypes in the early tumor microenvironment.
- To explore therapeutic strategies targeting microglia for early intervention against brain metastasis.
Main Methods:
- In vivo fate mapping and time-lapse imaging to track tumor cells and microglia.
- Single-cell RNA sequencing to analyze microglial transcriptional heterogeneity.
- Opto-omics (holographic photoconversion) for precise spatiotemporal manipulation.
- Genetic and pharmacological interventions to perturb microglial responses.
Main Results:
- Microglia exhibited significant transcriptional and morphological heterogeneity, with distinct pro- and anti-tumor subsets identified.
- Inhibiting transforming growth factor-beta (TGF-β) signaling altered microglial phenotypes.
- Deleting tumor cell surface antigens CD24a and CD47 modulated microglial states.
- Early microglial responses show plasticity that can be therapeutically targeted.
Conclusions:
- Microglial heterogeneity plays a critical role in the early stages of brain metastasis.
- Targeting TGF-β signaling or specific tumor antigens can reprogram microglia towards an anti-tumor state.
- Harnessing pro-phagocytic microglial functions presents a potential therapeutic window for early brain metastasis intervention.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...